The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 221 through 230 of 424 results (Download Results)

Show results per page

COVID-19 Variant Supplement – A low-cost, portable, and decentralized microfluidic device for detecting SARS-CoV-2 neutralizing antibodies

Little, Dustin J | Ryerson University | Operating Grant | $50,000

CIHR Ontario 2021

kitatipithitamak mithwayawin: Evaluating impacts of an existing Indigenous-led project on COVID-19, which includes past work on risk communication, present work on digital health, and a future international gathering for impacted Indigenous communities around the world.

Mclachlan, Stephane M | University of Manitoba | Other | $200,000

CIHR Manitoba 2021

A proposal to evaluate safer supply pilot programs in Canada

Werb, Daniel M | Unity Health Toronto | Operating Grant | $2,096,137

CIHR Ontario 2021

Pregnant and Lactating Individuals & Newborns COVID‑19 Vaccination Study

El-Chaar, Darine | Ottawa Hospital Research Institute | Operating Grant | $500,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID‑19 treatment

Lemieux, Joanne M | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2021

COVID-19 Variant Supplement – Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase

James, Michael N | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2021

Social polarization and behavioral intentions during the COVID‑19 pandemic: A multi-site study of risk and protective factors in Canadian youth

Rousseau, Cecile | McGill University | Project Grant | $240,975

CIHR Quebec 2021

Defining the impact of pre-existing host immunity on SARS-CoV-2 incidence and COVID‑19 clinical outcome

Kaul, Rupert | University of Toronto | Project Grant | $489,600

CIHR Ontario 2021

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Haas, Kurt | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

Impact of Frailty and Sarcopenia on Post-COVID Recovery

Afilalo, Jonathan | CIUSSS de Centre-Ouest-de-l'Ile-de-Montréal-Jewish General | Operating Grant | $470,179

CIHR Quebec 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – A low-cost, portable, and decentralized microfluidic device for detecting SARS-CoV-2 neutralizing antibodies

kitatipithitamak mithwayawin: Evaluating impacts of an existing Indigenous-led project on COVID-19, which includes past work on risk communication, present work on digital health, and a future international gathering for impacted Indigenous communities around the world.

A proposal to evaluate safer supply pilot programs in Canada

Pregnant and Lactating Individuals & Newborns COVID‑19 Vaccination Study

COVID-19 Variant Supplement – Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID‑19 treatment

COVID-19 Variant Supplement – Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase

Social polarization and behavioral intentions during the COVID‑19 pandemic: A multi-site study of risk and protective factors in Canadian youth

Defining the impact of pre-existing host immunity on SARS-CoV-2 incidence and COVID‑19 clinical outcome

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Impact of Frailty and Sarcopenia on Post-COVID Recovery